1h Free Analyst Time
Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company's operations and business divisions
- Corporate strategy - Analyst's summarization of the company's business strategy
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats
- Company history - Progression of key events associated with the company
- Major products and services - A list of major products, services and brands of the company
- Key competitors - A list of key competitors to the company
- Key employees - A list of the key executives of the company
- Executive biographies - A brief summary of the executives' employment history
- Key operational heads - A list of personnel heading key departments/functions
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history
Highlights
Azenta Inc (Azenta), formerly Brooks Automation Inc, is a provider of sample exploration and management solutions for the life sciences market. The company's portfolio includes automated cold storage systems, cryogenic storage systems, and consumables and instruments such as racks, tubes, cups, plates, and foils. Azenta also offers a comprehensive suite of informatics for planning, data management, virtualization, visualization, scheduling laboratory workflow, sampling inventory and logistics, monitoring environmental and temperature, and management of clinical trial and consent. The company's service offerings include component exchange, repair, spare parts, and upgrades. It has operations in Europe, Asia-Pacific, and North America. Azenta is headquartered in Chelmsford, Massachusetts, the US.Azenta Inc Key Recent Developments
Feb 08, 2023: Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022Nov 14, 2022: Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors
Nov 14, 2022: Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program
Nov 08, 2022: Azenta and the Government of Luxembourg announce a Memorandum of Understanding to facilitate continued healthcare technology development in Luxembourg
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitorsUnderstand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important eventsEquip yourself with information that enables you to sharpen your strategies and transform your operations profitably
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlightedScout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratiosGain key insights into the company for academic or business research
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needsNote: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company- Azenta Inc - Key Facts
- Azenta Inc - Key Employees
- Azenta Inc - Key Employee Biographies
- Azenta Inc - Major Products and Services
- Azenta Inc - History
- Azenta Inc - Company Statement
- Azenta Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Azenta Inc - Business Description
- Business Segment: Life Sciences Products
- Overview
- Performance
- Business Segment: Life Sciences Services
- Overview
- Performance
- Geographical Segment: Asia/Pacific/Other
- Performance
- Geographical Segment: China
- Performance
- Geographical Segment: Europe
- Performance
- Geographical Segment: North America
- Performance
- R&D Overview
- Azenta Inc - SWOT Analysis
- SWOT Analysis - Overview
- Azenta Inc - Strengths
- Azenta Inc - Weaknesses
- Azenta Inc - Opportunities
- Azenta Inc - Threats
- Azenta Inc - Key Competitors
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Azenta Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Azenta Inc, Recent Deals Summary
- Feb 08, 2023: Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022
- Nov 14, 2022: Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors
- Nov 14, 2022: Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program
- Nov 08, 2022: Azenta and the Government of Luxembourg announce a Memorandum of Understanding to facilitate continued healthcare technology development in Luxembourg
- Nov 07, 2022: Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
- Aug 09, 2022: Azenta agrees to purchase B Medical Systems for $469m
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- Azenta Inc, Key Facts
- Azenta Inc, Key Employees
- Azenta Inc, Key Employee Biographies
- Azenta Inc, Major Products and Services
- Azenta Inc, History
- Azenta Inc, Other Locations
- Azenta Inc, Subsidiaries
- Azenta Inc, Key Competitors
- Azenta Inc, Ratios based on current share price
- Azenta Inc, Annual Ratios
- Azenta Inc, Interim Ratios
- Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Azenta Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Azenta Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- Azenta Inc, Performance Chart (2017 - 2021)
- Azenta Inc, Ratio Charts
- Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Azenta Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023
Companies Mentioned
A selection of companies mentioned in this report includes:
- Twist Bioscience Corp
- Thermo Fisher Scientific Inc
- Rorze Corp
- Novogene Co Ltd
- Laboratory Corp of America Holdings
- Integrated DNA Technologies Inc
- Hirata Corp
- Hamilton Company
- Genscript Biotech Corp
- Eurofins Scientific SE
- BGI Genomics Co Ltd